Brief: Pharma Equity Group Consolidated Q3 Interim Report
Nov 16 (Reuters) - Pharma Equity Group A/S PEGRP.CO :
* CONSOLIDATED INTERIM REPORT 1 JANUARY – 30 SEPTEMBER 2023
* WE MAINTAIN PREVIOUSLY ANNOUNCED EXPECTATIONS FOR 2023
* Q3 OPERATING LOSS DKK 5.7 MILLION
* Q3 LOSS SEK 4.3 MILLION
Source text for Eikon: ID:nGNE4NnXbF
Further company coverage: PEGRP.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Pharma Equity A/S
See all newsBrief: PEG: Interpatium Commences Proceedings To Set Aside Arbitral Award
Brief: Pharma Equity Maintains Financial Guidance For 2026
Brief: Pharma Equity Group Unit Gets Patent Grant Notification
Brief: Pharma Equity Group To Borrow Up To About DKK 9.63 Million
Brief: Pharma Equity Group Adjusts 2025 Expectations